CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Adolescence presents a challenging time for type 1 diabetes management, and despite a multitude of studies aimed at increasing disease compl...
Indianapolis, Indiana, United States and 1 other location
The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...
Phase 4
Indianapolis, Indiana, United States and 9 other locations
Objectives The objective of this clinical trial is to assess whether ladarixin treatment has an effect to preserve β-cell function and delay the prog...
Phase 2
Indianapolis, Indiana, United States and 56 other locations
Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled on one or more glucose lowering agent...
Indianapolis, Indiana, United States and 64 other locations
The goal of this clinical trial is to test a drug known as DFMO in people with Type 1 Diabetes (T1D). The main question\[s\] it aims to answ...
Phase 2
Indianapolis, Indiana, United States and 5 other locations
Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with typ...
Indianapolis, Indiana, United States and 37 other locations
control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes...
Phase 2
Indianapolis, Indiana, United States and 19 other locations
This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...
Phase 3
Avon, Indiana, United States and 175 other locations
The purpose of this study is to find out how well a new continuous glucose monitor works for people with diabetes. This study will test the ....
Indianapolis, Indiana, United States and 24 other locations
This study compares 2 medicines for type 2 diabetes: semaglutide (new medicine) and a dummy medicine (placebo). Semaglutide will be tested t...
Phase 3
Indianapolis, Indiana, United States and 72 other locations
Clinical trials
Research sites
Resources
Legal